cbdMD Inc (YCBD)
0.4605
0.00 (0.00%)
USD |
NYAM |
Nov 22, 16:00
0.4726
+0.01
(+2.63%)
After-Hours: 20:00
cbdMD Revenue (Quarterly): 5.174M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 5.174M |
| March 31, 2024 | 4.376M |
| December 31, 2023 | 5.375M |
| September 30, 2023 | 5.711M |
| June 30, 2023 | 6.119M |
| March 31, 2023 | 6.24M |
| December 31, 2022 | 6.085M |
| September 30, 2022 | 7.860M |
| June 30, 2022 | 8.593M |
| March 31, 2022 | 9.629M |
| December 31, 2021 | 9.322M |
| September 30, 2021 | 9.793M |
| June 30, 2021 | 10.56M |
| March 31, 2021 | 11.80M |
| December 31, 2020 | 12.33M |
| September 30, 2020 | 11.70M |
| June 30, 2020 | 10.64M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.399M |
| December 31, 2019 | 10.15M |
| September 30, 2019 | 9.544M |
| June 30, 2019 | 8.005M |
| March 31, 2019 | 5.637M |
| December 31, 2018 | 0.4657M |
| September 30, 2018 | -6.508M |
| June 30, 2018 | 3.198M |
| March 31, 2018 | 3.081M |
| December 31, 2017 | 0.6878M |
| September 30, 2017 | 1.080M |
| June 30, 2017 | 1.787M |
| March 31, 2017 | 1.408M |
| December 31, 2016 | 0.1998M |
| September 30, 2016 | 0.2302M |
| June 30, 2016 | 0.3855M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
4.376M
Minimum
Mar 2024
12.33M
Maximum
Dec 2020
8.466M
Average
9.322M
Median
Dec 2021
Revenue (Quarterly) Benchmarks
| MariMed Inc | 40.59M |
| Flora Growth Corp | 12.46M |
| NovaBay Pharmaceuticals Inc | 2.441M |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.4597M |
| Total Expenses (Quarterly) | 5.556M |
| EPS Diluted (Quarterly) | -0.15 |
| Enterprise Value | 0.7209M |
| Gross Profit Margin (Quarterly) | 65.78% |
| Profit Margin (Quarterly) | 8.89% |
| Earnings Yield | -2.44K% |
| Normalized Earnings Yield | -1360.27 |